Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion type Assertion NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_head.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion description "[Treatment with anti-CD44 antibodies in NPC parental cells not only resulted in a decrease of FLJ10540 protein, but also affected the abilities of FLJ10540-elicited cell growth and motility in osteopontin stimulated-NPC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_provenance.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion evidence source_evidence_literature NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_provenance.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion SIO_000772 22591637 NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_provenance.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion wasDerivedFrom befree-20140225 NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_provenance.
- NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_assertion wasGeneratedBy ECO_0000203 NP731622.RALtMJqFUL5E5sdAzbT-Ft9Tns5Sl9HCWB2RMxLj1ciQo130_provenance.